IEM Innovation Simplifies Risk Management for High Blood Pressure - PWV an Emerging Predictor

Food and Healthcare Press Releases Monday November 10, 2014 08:32
STOLBERG, Germany--10 Nov--PRNewswire/InfoQuest

The individual risk of stroke, kidney failure and heart attack is the decisive factor over whether to start treatment for high blood pressure or increased cholesterol. The risk can be identified at any early stage by measuring the pulse wave velocity (PWV).

IEM - based in Stolberg/Germany - will present the clinically validated PWV system, "Measuring blood pressure and PWV in one", at Medica 2014.

Scientific data shows that the PWV is an independent predictor for cardiovascular events and is significantly superior to simply evaluating traditional risk factors, e.g. increased blood pressure or cholesterol or risk assessment based on the Framingham risk score.

The basic principle of the innovative PWV test method is the combination of blood pressure measurement and pulse wave analysis. PWV is considered the gold standard in arterial stiffness evaluation. It is well known that the stiffer the arteries, the greater the risk of cardiovascular diseases.

The benefit to patients and medical practitioners is the differentiation between vascular health and cardiovascular risk. The advantage is that by measuring the upper-arm blood pressure and PWV in one, a patient can be classified into "low risk" or "very high risk". This provides to the doctor a quick and solid basis for taking a decision on treatment.

The first comprehensive validated test system with the upper-arm cuff is the Mobil-O-Graph(R), which was validated against invasive catheterisation under very strict conditions.
Visit IEM GmbH at Medica from 12th - 15th November 2014 in Hall 9, Stand C68. Have your blood pressure pulse wave analysis performed.
Contactaddress for complete article and editing
I.E.M. GmbH
Cockerillstr. 69
D-52222 Stolberg
Tel: +49-2402-95-000
Fax: +49-2402-95-00-11
E-Mail: info@iem.de
Internet: http://www.iem.de
Source: I.E.M. GmbH

Latest Press Release

Walgreens Boots Alliance and Microsoft establish strategic partnership to transform health care delivery

- Companies aim to improve health outcomes and lower overall costs with enhanced digital and retail experiences and an R&D commitment to build health care solutions through seven-year agreement Walgreens Boots Alliance Inc. (WBA) and Microsoft Corp....

Ascensia Diabetes Care Announces Global Partnership With POCTech to Distribute and Co-develop Continuous Glucose Monitoring Systems

Ascensia Diabetes Care today announced it has entered into a global alliance with Zhejiang POCTech, Co., Ltd (POCTech), a developer and manufacturer of continuous glucose monitoring (CGM) systems. (Logo:...

MGI Announces Milestone of 1,000 Sequencers Installed and Opens Early Access Program for Groundbreaking Ultra-High-Throughput Sequencer, MGISEQ-T7

MGI, established in 2016 as a subsidiary of global genomics leader BGI Group, announced it has reached a new milestone of 1,000 MGI sequencers installed in 16 countries. MGI Chief Operating Officer Dr. Hui Jiang also announced the availability of MGI's...

Gift of Life Donor Program is U.S. Leader in Saving Lives

For the 11th consecutive year, Gift of Life Donor Program is the nation's leading organ procurement organization (OPO), coordinating the most life-saving organs for transplant among all 58 U.S. OPOs. Gift of Life broke two national records in 2018,...

Helsinn Group Grants Exclusive Licensing Rights to Menarini for Pracinostat

Licensing rights are worldwide excluding US, Canada, Japan and South AmericaHelsinn, a Swiss pharmaceutical group focused on building quality cancer care products, and Menarini, an Italian biopharmaceutical Group active in 136 countries worldwide, today...

Related Topics